Pharmaceutical News

RSS

Braeburn, Camurus announce FDA Fast Track designation for CAM2038 to treat opioid addiction

Braeburn Pharmaceuticals and Camurus announced today that the U.S. Food and Drug Administration granted Fast Track designation for the CAM2038 weekly and monthly buprenorphine subcutaneous injection products under development for the treatment of opioid addiction.

5 Nov 2015

ESCMID, ESWI call for increased flu vaccination coverage amongst healthcare professionals

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – is calling on the healthcare industry to lead by example and implement universal flu vaccination for healthcare workers.

5 Nov 2015

Nucala (mepolizumab) approved for treatment of asthma patients

The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older. Nucala is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.

5 Nov 2015

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.

4 Nov 2015

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Johnson & Johnson today announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.

4 Nov 2015

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.

4 Nov 2015

New study examines medications used by astronauts on long-duration spaceflight missions

If you are planning to take the long trip to Mars, don't forget to pack sleeping pills and skin cream. A new study published in the November 2015 issue of The FASEB Journal, is the first-ever examination of the medications used by astronauts on long-duration missions to the International Space Station.

4 Nov 2015

Study explores benefits of breast cancer adjuvant therapies

After breast cancer surgery, women are prescribed adjuvant (or follow-up) therapies such as chemotherapy and endocrine drugs to reduce the risk of the cancer returning. It's been assumed that the treatment effects of these therapies remain constant over time, but a new study from the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio suggests the opposite is true.

4 Nov 2015

Elderly women should take more vitamin D supplementation during the wintertime, suggests researchers

Osteoporosis is one of the chief reasons why the elderly often suffer broken bones from relatively minor injuries. Postmenopausal women in particular experience a relatively rapid loss in bone mass due to a reduced concentration of oestrogen, which is responsible for strong bone growth during youth. Maintaining bone mass requires physical exercise and vitamin D, which is mainly produced in the skin with the help of UVB radiation. This is why, especially in the wintertime, many elderly women are prescribed a vitamin D supplement by their doctor to maintain bone mass.

4 Nov 2015

ACI urges FDA to re-evaluate data relevant to safety, efficacy of antibacterial health care ingredients

The American Cleaning Institute urged the Food and Drug Administration to re-evaluate all data relevant to the safety and efficacy of antibacterial health care ingredients and make affirmative findings that they are generally recognized as safe and effective.

4 Nov 2015

Psychoactive drugs can help sedentary people to exercise, suggests Kent endurance expert

Endurance expert suggests drugs could help 'lazy people' exercise In what has been described as 'doping for lazy people' a University of Kent endurance expert has advocated the use of psychoactive drugs to encourage sedentary people to exercise.

4 Nov 2015

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).

3 Nov 2015

Expert proposes new solution to current gridlock over regulation of dietary supplements

A former principal deputy commissioner of the U.S. Food and Drug Administration is proposing a solution to the current gridlock over the regulation of dietary supplements: Focus less on whether these vitamins, minerals and herbal extracts actually do what they claim and instead take important steps to improve their safety.

3 Nov 2015

FHI 360, Accelovance collaborate to serve international drug development research efforts

Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in Oncology, Vaccines, and General Medicine and FHI 360, a global nonprofit organization with CRO capabilities focusing on clinical research in developing countries, have entered into a strategic alliance to more comprehensively serve the international drug development research efforts of pharmaceutical, governmental, and nonprofit organizations.

3 Nov 2015

Common heart drug may halt progression of angiosarcoma

A common heart drug may stop the progression of angiosarcoma, a cancer of the inner lining of blood vessels, according to a study by researchers at Texas Tech University Health Sciences Center El Paso.

3 Nov 2015

Discovery offers promising alternative to current therapies for AMD and ROP

A research team led by scientists at Beth Israel Deaconess Medical Center and the University of New Mexico School of Medicine has identified a small molecule that treats animal models of aged macular degeneration (AMD) and retinopathy of prematurity (ROP) by preventing the overgrowth of blood vessels that are characteristic of these two retinal diseases.

3 Nov 2015

Philidor Rx Services issues statement regarding termination of Valeant partnership

From day one, Philidor has been focused on providing patients the medication their doctors say they need quickly and efficiently.

3 Nov 2015

New initiative launched to accelerate search for effective HIV vaccine

A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today. Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020) brings together leading HIV researchers from public organisations and biotech companies from across Europe, Australia, Canada and the USA in a focused effort to develop protective and therapeutic HIV vaccines.

2 Nov 2015

Self-disseminating vaccines could prevent EID transmission from animals to humans

The 2014/2015 Ebola outbreak in West Africa shone the spotlight not only on the unpreparedness of local health services and science to deal with the pandemic, but also on the phenomenon of emerging infectious diseases (EIDs).

2 Nov 2015

Around 20% of ethnic school girls not vaccinated against HPV

Around 20 per cent of girls from ethnic minority backgrounds are not being vaccinated against the Human Papilloma Virus (HPV) because they feel they don't need to have it, according to a Cancer Research UK survey presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool*.

2 Nov 2015

Pharmaceutical News

Braeburn, Camurus announce FDA Fast Track designation for CAM2038 to treat opioid addiction

ESCMID, ESWI call for increased flu vaccination coverage amongst healthcare professionals

Nucala (mepolizumab) approved for treatment of asthma patients

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

New study examines medications used by astronauts on long-duration spaceflight missions

Study explores benefits of breast cancer adjuvant therapies

Elderly women should take more vitamin D supplementation during the wintertime, suggests researchers

ACI urges FDA to re-evaluate data relevant to safety, efficacy of antibacterial health care ingredients

Psychoactive drugs can help sedentary people to exercise, suggests Kent endurance expert

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Expert proposes new solution to current gridlock over regulation of dietary supplements

FHI 360, Accelovance collaborate to serve international drug development research efforts

Common heart drug may halt progression of angiosarcoma

Discovery offers promising alternative to current therapies for AMD and ROP

Philidor Rx Services issues statement regarding termination of Valeant partnership

New initiative launched to accelerate search for effective HIV vaccine

Self-disseminating vaccines could prevent EID transmission from animals to humans

Around 20% of ethnic school girls not vaccinated against HPV

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News